Yuli Li
P.R. China
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A novel prognostic biomarker combining TP53 loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy.
Journal: Oncology letters
Published: September 27, 2025
Correlative assessment of p53 immunostaining patterns and TP53 mutation status by next-generation sequencing in lung adenocarcinoma (LUAD).
Journal: Histopathology
Published: August 19, 2025
Case Report: Intestinal metastasis from ALK-rearranged pulmonary pleomorphic carcinomas mimicking inflammatory myofibroblastic tumors.
Journal: Frontiers in oncology
Published: September 15, 2024
Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene: Study of Two Typical Cases and Review of Literature.
Journal: Frontiers in medicine
Published: December 01, 2021
Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.
Journal: Human pathology
Published: December 31, 2020
Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method.
Journal: Translational lung cancer research
Published: March 25, 2020
Irradiated tumor cells of lipopolysaccharide stimulation elicit an enhanced anti-tumor immunity.
Journal: Journal of cancer research and clinical oncology
Published: January 14, 2014
Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer.
Journal: Journal of cancer research and clinical oncology
Published: November 15, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026